title: [Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?].
authors.forename: Keunhee
authors.initials: K
authors.lastname: Kang
authors.forename: Ji Hoon
authors.initials: JH
authors.lastname: Kim
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000821:virology*; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000821:virology*; D008297:Male
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens